SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'NOV'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AJ6_A_NOVA1_1 (GYRASE) |
1kij | DNA GYRASE SUBUNIT B (Thermusthermophilus) | 9 / 9 | ASN A 45GLU A 49ASP A 72ARG A 75ILE A 77PRO A 78ALA A 89ILE A 93THR A 166 | NOV A 400 (-3.8A)NOV A 400 (-3.6A)NOV A 400 (-3.1A)NOV A 400 (-3.4A)NOV A 400 (-4.1A)NOV A 400 (-4.4A)NOV A 400 ( 4.1A)NOV A 400 (-4.5A)NOV A 400 (-3.3A) | 0.46A | 1aj6A-1kijA:28.2 | 1aj6A-1kijA:35.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AJ6_A_NOVA1_1 (GYRASE) |
1s14 | TOPOISOMERASE IVSUBUNIT B (Escherichiacoli) | 8 / 9 | ASN A1042GLU A1046ASP A1069ARG A1072PRO A1075ALA A1086ILE A1090THR A1163 | NOV A1300 (-3.7A)NOV A1300 (-3.7A)NOV A1300 (-3.4A)NOV A1300 (-3.1A)NOV A1300 (-4.5A)NOV A1300 ( 4.3A)NOV A1300 ( 4.6A)NOV A1300 ( 4.0A) | 0.53A | 1aj6A-1s14A:23.3 | 1aj6A-1s14A:39.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AJ6_A_NOVA1_1 (GYRASE) |
3lps | TOPOISOMERASE IVSUBUNIT B (Xanthomonasoryzae) | 7 / 9 | ASN A 86GLU A 90ASP A 113ARG A 116PRO A 119ILE A 134THR A 207 | NOV A 901 (-4.0A)NOV A 901 (-3.8A)NOV A 901 (-3.5A)NOV A 901 (-3.4A)NOV A 901 (-4.5A)NOV A 901 ( 4.9A)NOV A 901 ( 4.2A) | 0.51A | 1aj6A-3lpsA:27.3 | 1aj6A-3lpsA:32.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AJ6_A_NOVA1_1 (GYRASE) |
4urn | DNA TOPOISOMERASEIV, B SUBUNIT (Staphylococcusaureus) | 7 / 9 | ASN A 49GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96THR A 168 | NOV A2000 (-3.8A)NOV A2000 (-3.4A)NOV A2000 (-3.5A)NOV A2000 (-3.2A)NOV A2000 (-4.1A)NOV A2000 (-4.2A)NOV A2000 (-3.9A) | 0.66A | 1aj6A-4urnA:29.1 | 1aj6A-4urnA:52.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B) |
1aj6 | GYRASE (Escherichiacoli) | 7 / 12 | GLU A 50ASP A 73ARG A 76ILE A 78PRO A 79ILE A 94THR A 165 | NOV A 1 (-3.8A)NOV A 1 (-3.5A)NOV A 1 (-3.5A)NOV A 1 (-4.1A)NOV A 1 (-4.2A)NOV A 1 ( 4.4A)NOV A 1 ( 4.1A) | 0.46A | 1kijA-1aj6A:28.2 | 1kijA-1aj6A:35.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B) |
1s14 | TOPOISOMERASE IVSUBUNIT B (Escherichiacoli) | 9 / 12 | ASP A1045GLU A1046ASP A1069ARG A1072PRO A1075ASP A1077ILE A1090ARG A1132THR A1163 | NoneNOV A1300 (-3.7A)NOV A1300 (-3.4A)NOV A1300 (-3.1A)NOV A1300 (-4.5A)NOV A1300 (-2.7A)NOV A1300 ( 4.6A)NOV A1300 (-2.9A)NOV A1300 ( 4.0A) | 0.31A | 1kijA-1s14A:24.0 | 1kijA-1s14A:27.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B) |
3lps | TOPOISOMERASE IVSUBUNIT B (Xanthomonasoryzae) | 9 / 12 | ASP A 89GLU A 90ASP A 113ARG A 116PRO A 119ASP A 121ILE A 134ARG A 176THR A 207 | NOV A 901 ( 4.8A)NOV A 901 (-3.8A)NOV A 901 (-3.5A)NOV A 901 (-3.4A)NOV A 901 (-4.5A)NOV A 901 (-2.6A)NOV A 901 ( 4.9A)NOV A 901 (-2.5A)NOV A 901 ( 4.2A) | 0.45A | 1kijA-3lpsA:39.5 | 1kijA-3lpsA:36.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B) |
4urn | DNA TOPOISOMERASEIV, B SUBUNIT (Staphylococcusaureus) | 8 / 12 | ASP A 52GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ARG A 138THR A 168 | NOV A2000 (-4.6A)NOV A2000 (-3.4A)NOV A2000 (-3.5A)NOV A2000 (-3.2A)NOV A2000 (-4.1A)NOV A2000 (-4.2A)NOV A2000 (-2.9A)NOV A2000 (-3.9A) | 0.89A | 1kijA-4urnA:27.9 | 1kijA-4urnA:32.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B) |
1aj6 | GYRASE (Escherichiacoli) | 8 / 12 | ASN A 46GLU A 50ASP A 73ARG A 76ILE A 78PRO A 79ILE A 94THR A 165 | NOV A 1 (-4.0A)NOV A 1 (-3.8A)NOV A 1 (-3.5A)NOV A 1 (-3.5A)NOV A 1 (-4.1A)NOV A 1 (-4.2A)NOV A 1 ( 4.4A)NOV A 1 ( 4.1A) | 0.42A | 1kijB-1aj6A:28.2 | 1kijB-1aj6A:35.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B) |
1s14 | TOPOISOMERASE IVSUBUNIT B (Escherichiacoli) | 9 / 12 | ASN A1042GLU A1046ASP A1069ARG A1072PRO A1075ASP A1077ILE A1090ARG A1132THR A1163 | NOV A1300 (-3.7A)NOV A1300 (-3.7A)NOV A1300 (-3.4A)NOV A1300 (-3.1A)NOV A1300 (-4.5A)NOV A1300 (-2.7A)NOV A1300 ( 4.6A)NOV A1300 (-2.9A)NOV A1300 ( 4.0A) | 0.38A | 1kijB-1s14A:24.5 | 1kijB-1s14A:27.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B) |
3lps | TOPOISOMERASE IVSUBUNIT B (Xanthomonasoryzae) | 9 / 12 | ASN A 86GLU A 90ASP A 113ARG A 116PRO A 119ASP A 121ILE A 134ARG A 176THR A 207 | NOV A 901 (-4.0A)NOV A 901 (-3.8A)NOV A 901 (-3.5A)NOV A 901 (-3.4A)NOV A 901 (-4.5A)NOV A 901 (-2.6A)NOV A 901 ( 4.9A)NOV A 901 (-2.5A)NOV A 901 ( 4.2A) | 0.53A | 1kijB-3lpsA:39.2 | 1kijB-3lpsA:36.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B) |
4urn | DNA TOPOISOMERASEIV, B SUBUNIT (Staphylococcusaureus) | 9 / 12 | ASN A 49GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ALA A 122ARG A 138THR A 168 | NOV A2000 (-3.8A)NOV A2000 (-3.4A)NOV A2000 (-3.5A)NOV A2000 (-3.2A)NOV A2000 (-4.1A)NOV A2000 (-4.2A)NOV A2000 ( 4.6A)NOV A2000 (-2.9A)NOV A2000 (-3.9A) | 0.78A | 1kijB-4urnA:28.2 | 1kijB-4urnA:32.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_A_NOVA1300_1 (TOPOISOMERASE IVSUBUNIT B) |
1aj6 | GYRASE (Escherichiacoli) | 7 / 12 | ASN A 46GLU A 50ASP A 73ARG A 76PRO A 79ILE A 94THR A 165 | NOV A 1 (-4.0A)NOV A 1 (-3.8A)NOV A 1 (-3.5A)NOV A 1 (-3.5A)NOV A 1 (-4.2A)NOV A 1 ( 4.4A)NOV A 1 ( 4.1A) | 0.51A | 1s14A-1aj6A:23.3 | 1s14A-1aj6A:39.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S14_A_NOVA1300_1 (TOPOISOMERASE IVSUBUNIT B) |
1kij | DNA GYRASE SUBUNIT B (Thermusthermophilus) | 10 / 12 | ASN A 45ASP A 48GLU A 49ASP A 72ARG A 75PRO A 78ASP A 80ILE A 93ARG A 135THR A 166 | NOV A 400 (-3.8A)NOV A 400 (-4.5A)NOV A 400 (-3.6A)NOV A 400 (-3.1A)NOV A 400 (-3.4A)NOV A 400 (-4.4A)NOV A 400 (-2.8A)NOV A 400 (-4.5A)NOV A 400 (-2.7A)NOV A 400 (-3.3A) | 0.38A | 1s14A-1kijA:24.0 | 1s14A-1kijA:27.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_A_NOVA1300_1 (TOPOISOMERASE IVSUBUNIT B) |
3lps | TOPOISOMERASE IVSUBUNIT B (Xanthomonasoryzae) | 12 / 12 | ASN A 86SER A 87ASP A 89GLU A 90ASP A 113ARG A 116MET A 118PRO A 119ASP A 121ILE A 134ARG A 176THR A 207 | NOV A 901 (-4.0A)NOV A 901 (-3.3A)NOV A 901 ( 4.8A)NOV A 901 (-3.8A)NOV A 901 (-3.5A)NOV A 901 (-3.4A)NOV A 901 (-3.7A)NOV A 901 (-4.5A)NOV A 901 (-2.6A)NOV A 901 ( 4.9A)NOV A 901 (-2.5A)NOV A 901 ( 4.2A) | 0.46A | 1s14A-3lpsA:27.5 | 1s14A-3lpsA:41.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_A_NOVA1300_1 (TOPOISOMERASE IVSUBUNIT B) |
4urn | DNA TOPOISOMERASEIV, B SUBUNIT (Staphylococcusaureus) | 11 / 12 | ASN A 49SER A 50ASP A 52GLU A 53ASP A 76ARG A 79MET A 81PRO A 82ILE A 96ARG A 138THR A 168 | NOV A2000 (-3.8A)NOV A2000 ( 3.7A)NOV A2000 (-4.6A)NOV A2000 (-3.4A)NOV A2000 (-3.5A)NOV A2000 (-3.2A)NOV A2000 (-3.8A)NOV A2000 (-4.1A)NOV A2000 (-4.2A)NOV A2000 (-2.9A)NOV A2000 (-3.9A) | 0.79A | 1s14A-4urnA:24.9 | 1s14A-4urnA:38.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_B_NOVB2300_1 (TOPOISOMERASE IVSUBUNIT B) |
1aj6 | GYRASE (Escherichiacoli) | 7 / 12 | ASN A 46GLU A 50ASP A 73ARG A 76PRO A 79ALA A 90ILE A 94 | NOV A 1 (-4.0A)NOV A 1 (-3.8A)NOV A 1 (-3.5A)NOV A 1 (-3.5A)NOV A 1 (-4.2A)NOV A 1 ( 3.9A)NOV A 1 ( 4.4A) | 0.53A | 1s14B-1aj6A:25.4 | 1s14B-1aj6A:39.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S14_B_NOVB2300_1 (TOPOISOMERASE IVSUBUNIT B) |
1kij | DNA GYRASE SUBUNIT B (Thermusthermophilus) | 10 / 12 | ASN A 45ASP A 48GLU A 49ASP A 72ARG A 75PRO A 78ASP A 80ALA A 89ILE A 93ARG A 135 | NOV A 400 (-3.8A)NOV A 400 (-4.5A)NOV A 400 (-3.6A)NOV A 400 (-3.1A)NOV A 400 (-3.4A)NOV A 400 (-4.4A)NOV A 400 (-2.8A)NOV A 400 ( 4.1A)NOV A 400 (-4.5A)NOV A 400 (-2.7A) | 0.43A | 1s14B-1kijA:26.2 | 1s14B-1kijA:27.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_B_NOVB2300_1 (TOPOISOMERASE IVSUBUNIT B) |
3lps | TOPOISOMERASE IVSUBUNIT B (Xanthomonasoryzae) | 11 / 12 | ASN A 86SER A 87ASP A 89GLU A 90ASP A 113ARG A 116MET A 118PRO A 119ASP A 121ILE A 134ARG A 176 | NOV A 901 (-4.0A)NOV A 901 (-3.3A)NOV A 901 ( 4.8A)NOV A 901 (-3.8A)NOV A 901 (-3.5A)NOV A 901 (-3.4A)NOV A 901 (-3.7A)NOV A 901 (-4.5A)NOV A 901 (-2.6A)NOV A 901 ( 4.9A)NOV A 901 (-2.5A) | 0.55A | 1s14B-3lpsA:29.8 | 1s14B-3lpsA:41.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_B_NOVB2300_1 (TOPOISOMERASE IVSUBUNIT B) |
4urn | DNA TOPOISOMERASEIV, B SUBUNIT (Staphylococcusaureus) | 10 / 12 | ASN A 49SER A 50ASP A 52GLU A 53ASP A 76ARG A 79MET A 81PRO A 82ILE A 96ARG A 138 | NOV A2000 (-3.8A)NOV A2000 ( 3.7A)NOV A2000 (-4.6A)NOV A2000 (-3.4A)NOV A2000 (-3.5A)NOV A2000 (-3.2A)NOV A2000 (-3.8A)NOV A2000 (-4.1A)NOV A2000 (-4.2A)NOV A2000 (-2.9A) | 0.92A | 1s14B-4urnA:26.9 | 1s14B-4urnA:38.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7H_B_SAMB530_0 (TYPE I RESTRICTIONENZYME ECOKI MPROTEIN) |
1aj6 | GYRASE (Escherichiacoli) | 5 / 12 | ILE A 134ALA A 47GLY A 77ASN A 198LEU A 194 | NoneNOV A 1 ( 4.2A)NoneNoneNone | 1.03A | 2y7hB-1aj6A:undetectable | 2y7hB-1aj6A:17.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LPS_A_NOVA901_1 (TOPOISOMERASE IVSUBUNIT B) |
1aj6 | GYRASE (Escherichiacoli) | 7 / 12 | ASN A 46GLU A 50ASP A 73ARG A 76PRO A 79ILE A 94THR A 165 | NOV A 1 (-4.0A)NOV A 1 (-3.8A)NOV A 1 (-3.5A)NOV A 1 (-3.5A)NOV A 1 (-4.2A)NOV A 1 ( 4.4A)NOV A 1 ( 4.1A) | 0.51A | 3lpsA-1aj6A:27.3 | 3lpsA-1aj6A:32.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LPS_A_NOVA901_1 (TOPOISOMERASE IVSUBUNIT B) |
1kij | DNA GYRASE SUBUNIT B (Thermusthermophilus) | 10 / 12 | ASN A 45ASP A 48GLU A 49ASP A 72ARG A 75PRO A 78ASP A 80ILE A 93ARG A 135THR A 166 | NOV A 400 (-3.8A)NOV A 400 (-4.5A)NOV A 400 (-3.6A)NOV A 400 (-3.1A)NOV A 400 (-3.4A)NOV A 400 (-4.4A)NOV A 400 (-2.8A)NOV A 400 (-4.5A)NOV A 400 (-2.7A)NOV A 400 (-3.3A) | 0.50A | 3lpsA-1kijA:39.5 | 3lpsA-1kijA:36.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LPS_A_NOVA901_1 (TOPOISOMERASE IVSUBUNIT B) |
1s14 | TOPOISOMERASE IVSUBUNIT B (Escherichiacoli) | 12 / 12 | ASN A1042SER A1043ASP A1045GLU A1046ASP A1069ARG A1072MET A1074PRO A1075ASP A1077ILE A1090ARG A1132THR A1163 | NOV A1300 (-3.7A)NOV A1300 (-3.6A)NoneNOV A1300 (-3.7A)NOV A1300 (-3.4A)NOV A1300 (-3.1A)NOV A1300 (-3.7A)NOV A1300 (-4.5A)NOV A1300 (-2.7A)NOV A1300 ( 4.6A)NOV A1300 (-2.9A)NOV A1300 ( 4.0A) | 0.46A | 3lpsA-1s14A:27.5 | 3lpsA-1s14A:41.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LPS_A_NOVA901_1 (TOPOISOMERASE IVSUBUNIT B) |
4urn | DNA TOPOISOMERASEIV, B SUBUNIT (Staphylococcusaureus) | 11 / 12 | ASN A 49SER A 50ASP A 52GLU A 53ASP A 76ARG A 79MET A 81PRO A 82ILE A 96ARG A 138THR A 168 | NOV A2000 (-3.8A)NOV A2000 ( 3.7A)NOV A2000 (-4.6A)NOV A2000 (-3.4A)NOV A2000 (-3.5A)NOV A2000 (-3.2A)NOV A2000 (-3.8A)NOV A2000 (-4.1A)NOV A2000 (-4.2A)NOV A2000 (-2.9A)NOV A2000 (-3.9A) | 0.69A | 3lpsA-4urnA:27.9 | 3lpsA-4urnA:30.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_A_NOVA2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
1aj6 | GYRASE (Escherichiacoli) | 7 / 11 | ASN A 46GLU A 50ASP A 73ARG A 76PRO A 79ILE A 94THR A 165 | NOV A 1 (-4.0A)NOV A 1 (-3.8A)NOV A 1 (-3.5A)NOV A 1 (-3.5A)NOV A 1 (-4.2A)NOV A 1 ( 4.4A)NOV A 1 ( 4.1A) | 0.66A | 4urnA-1aj6A:29.1 | 4urnA-1aj6A:52.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_A_NOVA2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
1kij | DNA GYRASE SUBUNIT B (Thermusthermophilus) | 9 / 11 | ASN A 45ASP A 48GLU A 49ASP A 72ARG A 75PRO A 78ILE A 93ARG A 135THR A 166 | NOV A 400 (-3.8A)NOV A 400 (-4.5A)NOV A 400 (-3.6A)NOV A 400 (-3.1A)NOV A 400 (-3.4A)NOV A 400 (-4.4A)NOV A 400 (-4.5A)NOV A 400 (-2.7A)NOV A 400 (-3.3A) | 0.85A | 4urnA-1kijA:27.9 | 4urnA-1kijA:32.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_A_NOVA2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
1s14 | TOPOISOMERASE IVSUBUNIT B (Escherichiacoli) | 11 / 11 | ASN A1042SER A1043ASP A1045GLU A1046ASP A1069ARG A1072MET A1074PRO A1075ILE A1090ARG A1132THR A1163 | NOV A1300 (-3.7A)NOV A1300 (-3.6A)NoneNOV A1300 (-3.7A)NOV A1300 (-3.4A)NOV A1300 (-3.1A)NOV A1300 (-3.7A)NOV A1300 (-4.5A)NOV A1300 ( 4.6A)NOV A1300 (-2.9A)NOV A1300 ( 4.0A) | 0.79A | 4urnA-1s14A:24.9 | 4urnA-1s14A:38.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_A_NOVA2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
3lps | TOPOISOMERASE IVSUBUNIT B (Xanthomonasoryzae) | 11 / 11 | ASN A 86SER A 87ASP A 89GLU A 90ASP A 113ARG A 116MET A 118PRO A 119ILE A 134ARG A 176THR A 207 | NOV A 901 (-4.0A)NOV A 901 (-3.3A)NOV A 901 ( 4.8A)NOV A 901 (-3.8A)NOV A 901 (-3.5A)NOV A 901 (-3.4A)NOV A 901 (-3.7A)NOV A 901 (-4.5A)NOV A 901 ( 4.9A)NOV A 901 (-2.5A)NOV A 901 ( 4.2A) | 0.69A | 4urnA-3lpsA:27.9 | 4urnA-3lpsA:30.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_B_NOVB2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
1aj6 | GYRASE (Escherichiacoli) | 7 / 11 | ASN A 46GLU A 50ASP A 73ARG A 76PRO A 79ILE A 94THR A 165 | NOV A 1 (-4.0A)NOV A 1 (-3.8A)NOV A 1 (-3.5A)NOV A 1 (-3.5A)NOV A 1 (-4.2A)NOV A 1 ( 4.4A)NOV A 1 ( 4.1A) | 0.56A | 4urnB-1aj6A:26.2 | 4urnB-1aj6A:52.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_B_NOVB2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
1kij | DNA GYRASE SUBUNIT B (Thermusthermophilus) | 9 / 11 | ASN A 45ASP A 48GLU A 49ASP A 72ARG A 75PRO A 78ILE A 93ARG A 135THR A 166 | NOV A 400 (-3.8A)NOV A 400 (-4.5A)NOV A 400 (-3.6A)NOV A 400 (-3.1A)NOV A 400 (-3.4A)NOV A 400 (-4.4A)NOV A 400 (-4.5A)NOV A 400 (-2.7A)NOV A 400 (-3.3A) | 0.72A | 4urnB-1kijA:25.9 | 4urnB-1kijA:32.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_B_NOVB2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
1s14 | TOPOISOMERASE IVSUBUNIT B (Escherichiacoli) | 11 / 11 | ASN A1042SER A1043ASP A1045GLU A1046ASP A1069ARG A1072MET A1074PRO A1075ILE A1090ARG A1132THR A1163 | NOV A1300 (-3.7A)NOV A1300 (-3.6A)NoneNOV A1300 (-3.7A)NOV A1300 (-3.4A)NOV A1300 (-3.1A)NOV A1300 (-3.7A)NOV A1300 (-4.5A)NOV A1300 ( 4.6A)NOV A1300 (-2.9A)NOV A1300 ( 4.0A) | 0.63A | 4urnB-1s14A:26.4 | 4urnB-1s14A:38.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_B_NOVB2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
3lps | TOPOISOMERASE IVSUBUNIT B (Xanthomonasoryzae) | 11 / 11 | ASN A 86SER A 87ASP A 89GLU A 90ASP A 113ARG A 116MET A 118PRO A 119ILE A 134ARG A 176THR A 207 | NOV A 901 (-4.0A)NOV A 901 (-3.3A)NOV A 901 ( 4.8A)NOV A 901 (-3.8A)NOV A 901 (-3.5A)NOV A 901 (-3.4A)NOV A 901 (-3.7A)NOV A 901 (-4.5A)NOV A 901 ( 4.9A)NOV A 901 (-2.5A)NOV A 901 ( 4.2A) | 0.57A | 4urnB-3lpsA:26.2 | 4urnB-3lpsA:30.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_C_NOVC2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
1aj6 | GYRASE (Escherichiacoli) | 7 / 11 | ASN A 46GLU A 50ASP A 73ARG A 76PRO A 79ILE A 94THR A 165 | NOV A 1 (-4.0A)NOV A 1 (-3.8A)NOV A 1 (-3.5A)NOV A 1 (-3.5A)NOV A 1 (-4.2A)NOV A 1 ( 4.4A)NOV A 1 ( 4.1A) | 0.60A | 4urnC-1aj6A:28.2 | 4urnC-1aj6A:52.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_C_NOVC2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
1kij | DNA GYRASE SUBUNIT B (Thermusthermophilus) | 9 / 11 | ASN A 45ASP A 48GLU A 49ASP A 72ARG A 75PRO A 78ILE A 93ARG A 135THR A 166 | NOV A 400 (-3.8A)NOV A 400 (-4.5A)NOV A 400 (-3.6A)NOV A 400 (-3.1A)NOV A 400 (-3.4A)NOV A 400 (-4.4A)NOV A 400 (-4.5A)NOV A 400 (-2.7A)NOV A 400 (-3.3A) | 0.69A | 4urnC-1kijA:28.2 | 4urnC-1kijA:32.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_C_NOVC2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
1s14 | TOPOISOMERASE IVSUBUNIT B (Escherichiacoli) | 11 / 11 | ASN A1042SER A1043ASP A1045GLU A1046ASP A1069ARG A1072MET A1074PRO A1075ILE A1090ARG A1132THR A1163 | NOV A1300 (-3.7A)NOV A1300 (-3.6A)NoneNOV A1300 (-3.7A)NOV A1300 (-3.4A)NOV A1300 (-3.1A)NOV A1300 (-3.7A)NOV A1300 (-4.5A)NOV A1300 ( 4.6A)NOV A1300 (-2.9A)NOV A1300 ( 4.0A) | 0.61A | 4urnC-1s14A:25.2 | 4urnC-1s14A:38.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_C_NOVC2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
3lps | TOPOISOMERASE IVSUBUNIT B (Xanthomonasoryzae) | 11 / 11 | ASN A 86SER A 87ASP A 89GLU A 90ASP A 113ARG A 116MET A 118PRO A 119ILE A 134ARG A 176THR A 207 | NOV A 901 (-4.0A)NOV A 901 (-3.3A)NOV A 901 ( 4.8A)NOV A 901 (-3.8A)NOV A 901 (-3.5A)NOV A 901 (-3.4A)NOV A 901 (-3.7A)NOV A 901 (-4.5A)NOV A 901 ( 4.9A)NOV A 901 (-2.5A)NOV A 901 ( 4.2A) | 0.56A | 4urnC-3lpsA:27.9 | 4urnC-3lpsA:30.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B) |
1aj6 | GYRASE (Escherichiacoli) | 7 / 12 | ASN A 46GLU A 50ASP A 73ARG A 76ILE A 78PRO A 79ILE A 94 | NOV A 1 (-4.0A)NOV A 1 (-3.8A)NOV A 1 (-3.5A)NOV A 1 (-3.5A)NOV A 1 (-4.1A)NOV A 1 (-4.2A)NOV A 1 ( 4.4A) | 0.41A | 4uroA-1aj6A:28.5 | 4uroA-1aj6A:55.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B) |
1kij | DNA GYRASE SUBUNIT B (Thermusthermophilus) | 9 / 12 | ASN A 45GLU A 49ASP A 72ARG A 75ILE A 77PRO A 78ASP A 80ILE A 93ARG A 135 | NOV A 400 (-3.8A)NOV A 400 (-3.6A)NOV A 400 (-3.1A)NOV A 400 (-3.4A)NOV A 400 (-4.1A)NOV A 400 (-4.4A)NOV A 400 (-2.8A)NOV A 400 (-4.5A)NOV A 400 (-2.7A) | 0.44A | 4uroA-1kijA:28.0 | 4uroA-1kijA:32.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B) |
1s14 | TOPOISOMERASE IVSUBUNIT B (Escherichiacoli) | 9 / 12 | ASN A1042SER A1043GLU A1046ASP A1069ARG A1072PRO A1075ASP A1077ILE A1090ARG A1132 | NOV A1300 (-3.7A)NOV A1300 (-3.6A)NOV A1300 (-3.7A)NOV A1300 (-3.4A)NOV A1300 (-3.1A)NOV A1300 (-4.5A)NOV A1300 (-2.7A)NOV A1300 ( 4.6A)NOV A1300 (-2.9A) | 0.49A | 4uroA-1s14A:26.0 | 4uroA-1s14A:37.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B) |
3lps | TOPOISOMERASE IVSUBUNIT B (Xanthomonasoryzae) | 9 / 12 | ASN A 86SER A 87GLU A 90ASP A 113ARG A 116PRO A 119ASP A 121ILE A 134ARG A 176 | NOV A 901 (-4.0A)NOV A 901 (-3.3A)NOV A 901 (-3.8A)NOV A 901 (-3.5A)NOV A 901 (-3.4A)NOV A 901 (-4.5A)NOV A 901 (-2.6A)NOV A 901 ( 4.9A)NOV A 901 (-2.5A) | 0.52A | 4uroA-3lpsA:27.5 | 4uroA-3lpsA:30.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B) |
4urn | DNA TOPOISOMERASEIV, B SUBUNIT (Staphylococcusaureus) | 8 / 12 | ASN A 49SER A 50GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ARG A 138 | NOV A2000 (-3.8A)NOV A2000 ( 3.7A)NOV A2000 (-3.4A)NOV A2000 (-3.5A)NOV A2000 (-3.2A)NOV A2000 (-4.1A)NOV A2000 (-4.2A)NOV A2000 (-2.9A) | 0.66A | 4uroA-4urnA:30.0 | 4uroA-4urnA:58.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B) |
1aj6 | GYRASE (Escherichiacoli) | 7 / 12 | ASN A 46GLU A 50ASP A 73ARG A 76ILE A 78PRO A 79ILE A 94 | NOV A 1 (-4.0A)NOV A 1 (-3.8A)NOV A 1 (-3.5A)NOV A 1 (-3.5A)NOV A 1 (-4.1A)NOV A 1 (-4.2A)NOV A 1 ( 4.4A) | 0.50A | 4uroB-1aj6A:28.8 | 4uroB-1aj6A:55.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B) |
1kij | DNA GYRASE SUBUNIT B (Thermusthermophilus) | 9 / 12 | ASN A 45GLU A 49ASP A 72ARG A 75ILE A 77PRO A 78ASP A 80ILE A 93ARG A 135 | NOV A 400 (-3.8A)NOV A 400 (-3.6A)NOV A 400 (-3.1A)NOV A 400 (-3.4A)NOV A 400 (-4.1A)NOV A 400 (-4.4A)NOV A 400 (-2.8A)NOV A 400 (-4.5A)NOV A 400 (-2.7A) | 0.51A | 4uroB-1kijA:28.1 | 4uroB-1kijA:32.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B) |
1s14 | TOPOISOMERASE IVSUBUNIT B (Escherichiacoli) | 9 / 12 | ASN A1042SER A1043GLU A1046ASP A1069ARG A1072PRO A1075ASP A1077ILE A1090ARG A1132 | NOV A1300 (-3.7A)NOV A1300 (-3.6A)NOV A1300 (-3.7A)NOV A1300 (-3.4A)NOV A1300 (-3.1A)NOV A1300 (-4.5A)NOV A1300 (-2.7A)NOV A1300 ( 4.6A)NOV A1300 (-2.9A) | 0.52A | 4uroB-1s14A:26.1 | 4uroB-1s14A:37.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B) |
3lps | TOPOISOMERASE IVSUBUNIT B (Xanthomonasoryzae) | 9 / 12 | ASN A 86SER A 87GLU A 90ASP A 113ARG A 116PRO A 119ASP A 121ILE A 134ARG A 176 | NOV A 901 (-4.0A)NOV A 901 (-3.3A)NOV A 901 (-3.8A)NOV A 901 (-3.5A)NOV A 901 (-3.4A)NOV A 901 (-4.5A)NOV A 901 (-2.6A)NOV A 901 ( 4.9A)NOV A 901 (-2.5A) | 0.54A | 4uroB-3lpsA:27.6 | 4uroB-3lpsA:30.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B) |
4urn | DNA TOPOISOMERASEIV, B SUBUNIT (Staphylococcusaureus) | 8 / 12 | ASN A 49SER A 50GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ARG A 138 | NOV A2000 (-3.8A)NOV A2000 ( 3.7A)NOV A2000 (-3.4A)NOV A2000 (-3.5A)NOV A2000 (-3.2A)NOV A2000 (-4.1A)NOV A2000 (-4.2A)NOV A2000 (-2.9A) | 0.63A | 4uroB-4urnA:30.2 | 4uroB-4urnA:58.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B) |
1aj6 | GYRASE (Escherichiacoli) | 6 / 12 | ASN A 46GLU A 50ARG A 76PRO A 79ALA A 91ILE A 94 | NOV A 1 (-4.0A)NOV A 1 (-3.8A)NOV A 1 (-3.5A)NOV A 1 (-4.2A)NoneNOV A 1 ( 4.4A) | 1.36A | 4uroC-1aj6A:28.6 | 4uroC-1aj6A:55.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B) |
1aj6 | GYRASE (Escherichiacoli) | 8 / 12 | ASN A 46GLU A 50ASP A 73ARG A 76ILE A 78PRO A 79ALA A 90ILE A 94 | NOV A 1 (-4.0A)NOV A 1 (-3.8A)NOV A 1 (-3.5A)NOV A 1 (-3.5A)NOV A 1 (-4.1A)NOV A 1 (-4.2A)NOV A 1 ( 3.9A)NOV A 1 ( 4.4A) | 0.46A | 4uroC-1aj6A:28.6 | 4uroC-1aj6A:55.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B) |
1kij | DNA GYRASE SUBUNIT B (Thermusthermophilus) | 10 / 12 | ASN A 45GLU A 49ASP A 72ARG A 75ILE A 77PRO A 78ASP A 80ALA A 89ILE A 93ARG A 135 | NOV A 400 (-3.8A)NOV A 400 (-3.6A)NOV A 400 (-3.1A)NOV A 400 (-3.4A)NOV A 400 (-4.1A)NOV A 400 (-4.4A)NOV A 400 (-2.8A)NOV A 400 ( 4.1A)NOV A 400 (-4.5A)NOV A 400 (-2.7A) | 0.51A | 4uroC-1kijA:28.1 | 4uroC-1kijA:32.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B) |
1s14 | TOPOISOMERASE IVSUBUNIT B (Escherichiacoli) | 9 / 12 | ASN A1042GLU A1046ASP A1069ARG A1072PRO A1075ASP A1077ALA A1086ILE A1090ARG A1132 | NOV A1300 (-3.7A)NOV A1300 (-3.7A)NOV A1300 (-3.4A)NOV A1300 (-3.1A)NOV A1300 (-4.5A)NOV A1300 (-2.7A)NOV A1300 ( 4.3A)NOV A1300 ( 4.6A)NOV A1300 (-2.9A) | 0.54A | 4uroC-1s14A:26.0 | 4uroC-1s14A:37.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B) |
3lps | TOPOISOMERASE IVSUBUNIT B (Xanthomonasoryzae) | 8 / 12 | ASN A 86GLU A 90ASP A 113ARG A 116PRO A 119ASP A 121ILE A 134ARG A 176 | NOV A 901 (-4.0A)NOV A 901 (-3.8A)NOV A 901 (-3.5A)NOV A 901 (-3.4A)NOV A 901 (-4.5A)NOV A 901 (-2.6A)NOV A 901 ( 4.9A)NOV A 901 (-2.5A) | 0.53A | 4uroC-3lpsA:28.0 | 4uroC-3lpsA:30.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B) |
4urn | DNA TOPOISOMERASEIV, B SUBUNIT (Staphylococcusaureus) | 7 / 12 | ASN A 49GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ARG A 138 | NOV A2000 (-3.8A)NOV A2000 (-3.4A)NOV A2000 (-3.5A)NOV A2000 (-3.2A)NOV A2000 (-4.1A)NOV A2000 (-4.2A)NOV A2000 (-2.9A) | 0.65A | 4uroC-4urnA:30.5 | 4uroC-4urnA:58.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B) |
1aj6 | GYRASE (Escherichiacoli) | 8 / 12 | ASN A 46GLU A 50ASP A 73ARG A 76ILE A 78PRO A 79ILE A 94THR A 165 | NOV A 1 (-4.0A)NOV A 1 (-3.8A)NOV A 1 (-3.5A)NOV A 1 (-3.5A)NOV A 1 (-4.1A)NOV A 1 (-4.2A)NOV A 1 ( 4.4A)NOV A 1 ( 4.1A) | 0.43A | 4uroD-1aj6A:28.9 | 4uroD-1aj6A:55.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B) |
1kij | DNA GYRASE SUBUNIT B (Thermusthermophilus) | 10 / 12 | ASN A 45GLU A 49ASP A 72ARG A 75ILE A 77PRO A 78ASP A 80ILE A 93ARG A 135THR A 166 | NOV A 400 (-3.8A)NOV A 400 (-3.6A)NOV A 400 (-3.1A)NOV A 400 (-3.4A)NOV A 400 (-4.1A)NOV A 400 (-4.4A)NOV A 400 (-2.8A)NOV A 400 (-4.5A)NOV A 400 (-2.7A)NOV A 400 (-3.3A) | 0.40A | 4uroD-1kijA:27.4 | 4uroD-1kijA:32.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B) |
1s14 | TOPOISOMERASE IVSUBUNIT B (Escherichiacoli) | 10 / 12 | ASN A1042SER A1043GLU A1046ASP A1069ARG A1072PRO A1075ASP A1077ILE A1090ARG A1132THR A1163 | NOV A1300 (-3.7A)NOV A1300 (-3.6A)NOV A1300 (-3.7A)NOV A1300 (-3.4A)NOV A1300 (-3.1A)NOV A1300 (-4.5A)NOV A1300 (-2.7A)NOV A1300 ( 4.6A)NOV A1300 (-2.9A)NOV A1300 ( 4.0A) | 0.50A | 4uroD-1s14A:25.1 | 4uroD-1s14A:37.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B) |
3lps | TOPOISOMERASE IVSUBUNIT B (Xanthomonasoryzae) | 5 / 12 | ASN A 86ASP A 113ARG A 176ILE A 134THR A 207 | NOV A 901 (-4.0A)NOV A 901 (-3.5A)NOV A 901 (-2.5A)NOV A 901 ( 4.9A)NOV A 901 ( 4.2A) | 1.35A | 4uroD-3lpsA:27.1 | 4uroD-3lpsA:30.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B) |
3lps | TOPOISOMERASE IVSUBUNIT B (Xanthomonasoryzae) | 10 / 12 | ASN A 86SER A 87GLU A 90ASP A 113ARG A 116PRO A 119ASP A 121ILE A 134ARG A 176THR A 207 | NOV A 901 (-4.0A)NOV A 901 (-3.3A)NOV A 901 (-3.8A)NOV A 901 (-3.5A)NOV A 901 (-3.4A)NOV A 901 (-4.5A)NOV A 901 (-2.6A)NOV A 901 ( 4.9A)NOV A 901 (-2.5A)NOV A 901 ( 4.2A) | 0.49A | 4uroD-3lpsA:27.1 | 4uroD-3lpsA:30.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B) |
4urn | DNA TOPOISOMERASEIV, B SUBUNIT (Staphylococcusaureus) | 9 / 12 | ASN A 49SER A 50GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ARG A 138THR A 168 | NOV A2000 (-3.8A)NOV A2000 ( 3.7A)NOV A2000 (-3.4A)NOV A2000 (-3.5A)NOV A2000 (-3.2A)NOV A2000 (-4.1A)NOV A2000 (-4.2A)NOV A2000 (-2.9A)NOV A2000 (-3.9A) | 0.62A | 4uroD-4urnA:29.9 | 4uroD-4urnA:58.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NY7_A_NCAA303_0 (AMIDASE) |
1kij | DNA GYRASE SUBUNIT B (Thermusthermophilus) | 4 / 6 | ARG A 75PRO A 78THR A 166GLU A 49 | NOV A 400 (-3.4A)NOV A 400 (-4.4A)NOV A 400 (-3.3A)NOV A 400 (-3.6A) | 1.05A | 5ny7A-1kijA:undetectable | 5ny7A-1kijA:22.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6F88_B_STRB502_1 (CYTOCHROME P450CYP260A1) |
4urn | DNA TOPOISOMERASEIV, B SUBUNIT (Staphylococcusaureus) | 4 / 6 | LEU A 204LEU A 194SER A 50ASN A 209 | NoneNoneNOV A2000 ( 3.7A)None | 0.95A | 6f88B-4urnA:undetectable | 6f88B-4urnA:13.78 |